Celltrion Drug Patent Portfolio
Celltrion's Family Patents
Clinical Trials
Recent Clinical Trials by Celltrion:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin | Celltrion | NA |
COMPLETED
(May 1, 2026)
| PHASE3 |
| Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol | Celltrion Pharm, Inc. | NA |
COMPLETED
(May 1, 2026)
| PHASE3 |
| A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer | Celltrion | NA |
ACTIVE NOT RECRUITING
(Apr 1, 2026)
| PHASE3 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List